Key terms
About INVO
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest INVO news
Jan 23
8:09am ET
NAYA Biosciences to acquire Florida Biotechnologies
Jan 17
8:17am ET
INVO files S-4 registration, prelim joint proxy related merger with NAYA
Dec 11
8:11am ET
NAYA Biosciences announces new data for its Flex-NK bispecific antibody
Dec 06
9:06am ET
INVO Bioscience merger partner NAYA Biosciences signs research partnership
Nov 28
9:04am ET
INVO Bioscience regains Nasdaq compliance
Nov 09
4:45pm ET
INVO Bioscience solicits waivers from warrant holders
No recent press releases are available for INVO
INVO Financials
Key terms
Ad Feedback
INVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
INVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
